
Empowering investors with insights, analysis and expert recommendations to navigate financial markets with confidence.
Open a Free Trial Account Now to Start Receiving Timely High-Conviction Investment Ideas and Actionable Trade Signals Designed To Help You Stay Ahead, and also See Our Complete History of Past Investment and Trading Results.

Cygnus (ASX: CY5) Shares Soar on A$232M Takeover Bid; 60% Premium Sends CY5 Rallying
Jun 3, 2026 | Proactive Equities Team

Has Northern Star Resources (ASX: NST) Found a Reliable Long-Term Support Base?
Jun 3, 2026 | Proactive Equities Team

Pacgold (ASX: PGO) Surges Over 10% on Major Demerger Plan and Shift in Growth Focus
Jun 3, 2026 | Proactive Equities Team

Stakk (ASX: SKK) Surges on Growth Momentum After Record Revenue Expansion
Jun 3, 2026 | Proactive Equities Team

Has Tivan (ASX: TVN) Formed a Sustainable Long-Term Floor?
Jun 3, 2026 | Proactive Equities Team

Is Tamboran Resources Corporation (ASX: TBN) Uptrend Still Intact Following Its Pullback to Support?
Jun 1, 2026 | Proactive Equities Team

Cygnus Metals (ASX: CY5) has surged after a A$232 million takeover offer from Central Asia Metals, offering a 60% premium. The company focuses on developing its high-grade Chibougamau Copper-Gold Project in Québec, alongside lithium and base-metal exploration, while expanding resources through drilling and capital raising.

Pacgold shares jumped more than 10% after unveiling a major demerger that will spin out its North Queensland exploration assets into Manda Resources. The move allows Pacgold to focus on the producing White Dam Gold Operation while retaining exposure to exploration growth, strengthening its position as a gold producer and developer.

Stakk (ASX: SKK) has surged, reporting record $5.52 million in March quarter revenue and 186% growth, driven by its Stakk IQ embedded finance platform. Expanding across Australian and U.S. banks, healthcare, and regulated industries, it secured major contracts, lifting ARR toward A$26 million.

Tivan (ASX: TVN) develops critical minerals across Australia and Timor-Leste, led by the Speewah Fluorite project. Following a post-feasibility sell-off and rising cash burn, the stock faces a neutral-to-bearish technical outlook ahead of its late-2026 Final Investment Decision.

Tamboran Resources is a pre-production shale gas developer in the Beetaloo Basin, advancing toward first gas in 2026. Strong drilling results, contracts, and infrastructure progress support its uptrend, though risks remain around execution, funding, and market access beyond initial supply agreements.

Australian Mines (ASX: AUZ) is a critical minerals explorer focused on battery metals, rare earths, and gold across Australia and Brazil, advancing projects like Sconi and Flemington while leveraging strong commodity trends and strategic funding to drive its 2026 share price recovery.

Telix Pharmaceuticals (ASX: TLX) is recovering after a sharp biotech sell-off driven by regulatory and legal concerns. Renewed investor confidence follows strong revenue growth, progress in Phase 3, and a Regeneron partnership, with FY2026 revenue nearing US$1 billion and pipeline milestones advancing.

Neuren Pharmaceuticals (ASX: NEU) is a rare-disease biotech generating revenue from DAYBUE while advancing NNZ-2591. After declines from regulatory and guidance setbacks, improving US rollout and technical strength suggest a recovery, with the stock forming higher lows and testing key resistance levels.

Marmota (ASX: MEU) has surged back into focus after strong gains driven by high-grade drilling results from its Greenewood gold project in South Australia. Renewed exploration activity, rising gold prices, and aggressive drilling have boosted investor interest. The stock remains highly speculative but increasingly watched by ASX momentum traders.

Neurizon Therapeutics (ASX: NUZ) is a clinical-stage biotech developing NUZ-001 for ALS and other neurodegenerative diseases. Despite promising data and global trials, the stock faces pressure from clinical delays, dilution, rising losses, and ongoing uncertainty typical of pre-revenue biotech companies.

Northern Star Resources (ASX: NST) faces volatility as FY26 operational downgrades clash with strong gold prices and an A$500M buyback. Technically, the stock recently rebounded off key long-term trendline support near A $20, signalling a potential bullish recovery.

Elders' shares fell over 20% after investors focused on weaker FY26 guidance, rising input and fuel costs, integration risks, despite strong half-year earnings growth driven by better conditions and Delta Agribusiness contributions, highlighting concerns about future margins and outlook uncertainty.

Commonwealth Bank of Australia (ASX: CBA) is facing weakening medium-term momentum after a sharp sell-off triggered by a quarterly profit miss, valuation concerns, rising policy risks, and margin pressure. Technically, the stock remains in a long-term uptrend but is testing critical support near $160.

Fortescue (ASX: FMG) shares have rebounded on stronger iron ore prices, improving Chinese demand and solid shipments. Sentiment is also lifted by dividends and production strength, while its green energy transition and decarbonisation plans support long-term growth above A$20 momentum.

CSL shares crashed after a US$5 billion impairment warning and weaker guidance shocked investors, sending the stock below A$100. Despite strong long-term fundamentals in plasma therapies, technical indicators remain bearish with heavy selling pressure still dominating the chart.

Breville is a premium global small‑appliances brand leveraging coffee leadership, innovation and an asset‑light model to drive ~10% growth. Strong cash flow, balance sheet improvement and a growing Beanz ecosystem support a justified valuation premium despite tariff pressure.

This report highlights three high-yield ASX dividend stocks across different industries, offering strong income and upside potential over the next 6–12 months, backed by durable competitive advantages, profitable business models, and valuations that appear attractive relative to their long-term growth prospects.

Treasury Wine Estates shows early reversal signs after a downturn, supported by restructuring optimism and stabilising demand. Key upside lies around A$5.30–A$5.70, with further gains possible if momentum holds, though sustained strength is needed to confirm a broader recovery.

Cochlear’s share price slump reflects profit downgrades, slowing growth, weak global demand, and macro pressures. The stock is down sharply, but a lasting bottom likely depends on stabilising earnings and clearer signs of demand recovery.

Qantas (ASX: QAN) has pulled back sharply in 2026, but the decline is largely driven by cyclical pressures rather than a broken business. The key trigger has been a surge in jet fuel costs, which have more than doubled in recent months.

Investing in the Australian stock market offers stability, strong regulation, and exposure to globally essential industries like mining and finance. With diverse sectors and proximity to Asia’s growth, the ASX provides long-term opportunities in a mature, reliable market.

Rising fuel costs are speeding up EV adoption, with global sales surpassing 20 million in 2025 and now over 20% of new car sales. This directly boosts lithium demand, positioning ASX lithium stocks to benefit from both EV growth and pricing cycles.

Coal prices are rising as global energy disruptions, particularly gas supply issues linked to Middle East tensions, push utilities to switch to coal as a reliable fallback fuel. Strong electricity demand in Asia and limited short-term alternatives are further supporting demand. Australian coal producers are well positioned to benefit, with higher prices boosting margins and cash flow, making ASX-listed coal stocks a direct way to gain exposure to this trend.

Rising cyber threats, stricter regulations, and the rapid shift to cloud and AI systems are driving a sharp increase in global cybersecurity spending, and the ASX is starting to reflect that trend. The Australian cybersecurity market alone is expected to grow from about A$8.4 billion in 2025 to nearly A$19.6 billion by 2030, highlighting the scale of opportunity ahead.

Rising geopolitical tensions and military modernisation are driving a surge in global defence spending, which exceeded US$2.6 trillion in 2025. Australia is also increasing defence investment, with spending expected to approach A$100 billion by 2034. As a result, ASX-listed companies involved in defence technology, shipbuilding and security systems are gaining investor attention as part of a long-term growth trend.

Geopolitical tensions and supply disruptions have pushed global oil and gas prices higher. When benchmarks rise, ASX energy producers—especially upstream and LNG exporters—often see stronger revenues and margins due to robust demand from Asian markets.
.webp&w=828&q=75)
Markets faced a “soft-landing but sticky” backdrop: growth held up, yet inflation and policy uncertainty kept risk elevated and dispersion high. The US stayed resilient but uneven as labour demand cooled and the Fed remained cautious. The ECB stayed meeting-by-meeting. Australia felt higher-for-longer, rotating into defensives.

Global nickel prices have surged to near US$18,000 per tonne on supply concerns, particularly around potential production cuts in Indonesia and regulatory uncertainty. The rally has been amplified by speculative flows and broader base-metals momentum, despite elevated inventories and mixed demand fundamentals.

Zinc prices are edging higher as physical markets tighten, supported by steady demand from steel, infrastructure and renewable energy projects alongside shrinking exchange inventories, particularly on the LME. With supply growth limited and visibility low, declining stocks are increasing concerns around future availability, which can underpin higher prices. For ASX investors, this environment favours zinc-exposed producers, developers and explorers, as well as diversified miners with meaningful base-metal exposure, all of which stand to benefit from improving project economics and margins as zinc’s outlook strengthens.

Tin prices have been climbing sharply because the metal is suddenly caught between rising demand and tightening supply. Electronic devices, artificial intelligence hardware, solar panels and electric vehicles all rely on tin-based solder and components, pushing consumption higher just as long-neglected supply struggles to keep up. Production has been disrupted in key regions by political instability, mine closures and regulatory crackdowns, and underinvestment means new sources aren’t coming online fast enough. In this article we discuss some of the ASX stocks that can benefit the most from the rising tin prices.
Get access to Proactive Equities’ latest high conviction stock picks and trade signals
Our Standard Membership will give you access to
Our Dividend Portfolio
Our Growth Portfolio
High Conviction Buys Now
Sector Reports
Fortnightly Investor webinars
Weekly Macro Insights
Our Premium Membership will give you access to:
Short-term Trading Signals
Our Dividend Portfolio
Our Growth Portfolio
High Conviction Buys Now
Sector Reports
Fortnightly Investor webinars
Weekly Macro Insights
